Ledger.Open graph →
SEC Form D · filed March 25, 2026

AN2 Therapeutics, Inc

Offering
$40.0M
Sold
$40.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MENLO PARK, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Margaret L. Fitzpatrick · MENLO PARK, CADirectorPatricia L. Martin · MENLO PARK, CADirectorMelvin L. Spigelman · MENLO PARK, CADirectorGilbert L. Marks · MENLO PARK, CADirectorStephanie L. Wong · MENLO PARK, CADirectorJoseph S. Zakrzewski · LEXINGTON, MADirectorJoshua Eizen · MENLO PARK, CAExecKabeer S. Aziz · MENLO PARK, CADirectorRob S. Readnour · MENLO PARK, CADirectorSanjay Chanda · Palo Alto, CAExecLucy Day · MENLO PARK, CAExecEric Easom · MENLO PARK, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗